Entrada Therapeutics News

HHS Panel to Vote in Nov. on DMD Screening for Newborns

Seeking Alpha06:44

Entrada Therapeutics: A Strong Buy on Robust Financials and Promising DMD Therapeutic Pipeline

TipRanksMay 8 18:30

Entrada Therapeutics (TRDA.US): The 2024 Q1 financial report achieved revenue of $59.12 million, previous value of USD 25.26 million, expected value of USD 14.98 million; earnings per share was USD 0.68, previous value was -0.21 USD, and expected value wa

Entrada Therapeutics (TRDA.US): The 2024 Q1 financial report achieved revenue of $59.12 million, previous value of USD 25.26 million, expected value of USD 14.98 million; earnings per share was USD 0.68, previous value was -0.21 USD, and expected value was -0.59 USD.

Zhitong FinanceMay 7 21:31

Entrada Therapeutics Q1 2024 GAAP EPS $0.68 May Not Be Comparable To $(0.52) Estimate, Sales $59.120M May Not Be Comparable To $14.977M Estimate

Entrada Therapeutics Q1 2024 GAAP EPS $0.68 May Not Be Comparable To $(0.52) Estimate, Sales $59.120M May Not Be Comparable To $14.977M Estimate

BenzingaMay 7 19:26

Entrada Therapeutics | 10-Q: Quarterly report

Futu NewsMay 7 19:14 · Announcements

Entrada Therapeutics 1Q EPS 68c >TRDA

Entrada Therapeutics 1Q EPS 68c >TRDA

Dow JonesMay 7 19:01

Entrada Therapeutics Cash Runway Expected Through the 2Q of 2026 With $327M in Cash, Cash Equivalents and Marketable Securities as of March 31 >TRDA

Entrada Therapeutics Cash Runway Expected Through the 2Q of 2026 With $327M in Cash, Cash Equivalents and Marketable Securities as of March 31 >TRDA

Dow JonesMay 7 19:01

Press Release: Entrada Therapeutics Reports First Quarter 2024 Financial Results

Entrada Therapeutics Reports First Quarter 2024 Financial Results -- Initiated dosing of the fourth and final cohort of Phase 1 clinical trial of ENTR-601-44 for the potential treatment of DMD with d

Dow JonesMay 7 19:00

Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 168.53K in Common Stocks

SEC FILLINGS DISCLOSED/ Apr 29, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 13,729 shares of its common stock on Apr 29, with a total market value of approximately $168.53

Futu NewsApr 30 04:16

Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 152.48K in Common Stocks

SEC FILLINGS DISCLOSED/ Apr 25, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 12,483 shares of its common stock on Apr 25, with a total market value of approximately $152.48

Futu NewsApr 26 04:39

Edgewise Gets EU Orphan Drug Status for Muscular Dystrophy Drug

Seeking AlphaApr 23 22:29

Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 116.17K in Common Stocks

SEC FILLINGS DISCLOSED/ Apr 19, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 9,632 shares of its common stock on Apr 19, with a total market value of approximately $116.17K

Futu NewsApr 20 04:17

Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 112.7K in Common Stocks

SEC FILLINGS DISCLOSED/ Apr 18, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 9,311 shares of its common stock on Apr 18, with a total market value of approximately $112.7K.

Futu NewsApr 19 04:23

GLYC, APLD and AUTL Are Among After Hour Movers

Seeking AlphaApr 12 05:00

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersOntrak (NASDAQ:OTRK) shares increased by 18.7% to $0.45 during Thursday's after-market session. The company's market cap stands at $18.9 million. Ocuphire Pharma (NASDAQ:OCUP) stock rose 7.82%

BenzingaApr 12 04:31

Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 110.1K in Common Stocks

SEC FILLINGS DISCLOSED/ Apr 11, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 8,510 shares of its common stock on Apr 11, with a total market value of approximately $110.1K.

Futu NewsApr 12 04:26

Insiders Buying America's Car-Mart And 2 Other Stocks

Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the s

BenzingaApr 11 18:41

Entrada Therapeutics(TRDA.US) Director Buys US$35,289.8 in Common Stock

$Entrada Therapeutics(TRDA.US)$ Director KIM PETER S purchased 2,600 shares of common stock on Apr 8, 2024 at an average price of $13.573 for a total value of $35,289.8.Source: Announcement What is st

Futu NewsApr 11 05:18

Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 176.03K in Common Stocks

SEC FILLINGS DISCLOSED/ Apr 10, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 14,096 shares of its common stock on Apr 10, with a total market value of approximately $176.03

Futu NewsApr 11 04:19

Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 108.04K in Common Stocks

SEC FILLINGS DISCLOSED/ Apr 9, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 8,163 shares of its common stock on Apr 9, with a total market value of approximately $108.04K.

Futu NewsApr 10 04:17